UY31016A1 - Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos - Google Patents

Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos

Info

Publication number
UY31016A1
UY31016A1 UY31016A UY31016A UY31016A1 UY 31016 A1 UY31016 A1 UY 31016A1 UY 31016 A UY31016 A UY 31016A UY 31016 A UY31016 A UY 31016A UY 31016 A1 UY31016 A1 UY 31016A1
Authority
UY
Uruguay
Prior art keywords
preparation
new nitrogen
antibacterial medicines
compounds
heterociclic compounds
Prior art date
Application number
UY31016A
Other languages
English (en)
Inventor
Benoit Ledoussal
Adel Klebsi
David Rowland
Maxime Lampilas
Original Assignee
Novexel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novexel filed Critical Novexel
Publication of UY31016A1 publication Critical patent/UY31016A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/529—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invencion trata de compuestos heterocíclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos, los compuestos de formula general (I).
UY31016A 2007-04-12 2008-04-10 Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos UY31016A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0702663A FR2914923B1 (fr) 2007-04-12 2007-04-12 Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens.

Publications (1)

Publication Number Publication Date
UY31016A1 true UY31016A1 (es) 2008-11-28

Family

ID=38704839

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31016A UY31016A1 (es) 2007-04-12 2008-04-10 Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos

Country Status (30)

Country Link
US (1) US8063219B2 (es)
EP (1) EP2146994B1 (es)
JP (1) JP2010523630A (es)
KR (1) KR20090130126A (es)
CN (1) CN101687870B (es)
AR (1) AR066023A1 (es)
AU (1) AU2008252799B2 (es)
BR (1) BRPI0809593A2 (es)
CA (1) CA2683350A1 (es)
CL (1) CL2008001048A1 (es)
CO (1) CO6220973A2 (es)
CR (1) CR11057A (es)
CU (1) CU23854B1 (es)
EC (1) ECSP099682A (es)
FR (1) FR2914923B1 (es)
GT (1) GT200900266A (es)
HN (1) HN2009002099A (es)
IL (1) IL201252A (es)
MX (1) MX2009010837A (es)
MY (1) MY152839A (es)
NI (1) NI200900181A (es)
NZ (1) NZ580238A (es)
PA (1) PA8776401A1 (es)
PE (1) PE20090235A1 (es)
RU (1) RU2465276C2 (es)
SV (1) SV2009003391A (es)
TW (1) TWI403323B (es)
UY (1) UY31016A1 (es)
WO (1) WO2008142285A1 (es)
ZA (1) ZA200906784B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE308537T1 (de) * 2001-05-10 2005-11-15 Solvay Pharm Gmbh Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
AR090539A1 (es) 2012-04-02 2014-11-19 Astrazeneca Ab COMPUESTOS INHIBIDORES DE b LACTAMASA
UA111925C2 (uk) 2012-12-11 2016-06-24 Федора Фармасьютікалз Інк. БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
AU2015350128B2 (en) 2014-11-17 2019-05-16 Entasis Therapeutics Limited Combination therapy for treatment of resistant bacterial infections
KR102537340B1 (ko) 2016-09-16 2023-05-26 엔타시스 테라퓨틱스 리미티드 베타-락타마제 억제제 화합물
PE20200333A1 (es) 2017-05-08 2020-02-14 Entasis Therapeutics Inc Compuestos y metodos para tratar infecciones bacterianas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2848210B1 (fr) * 2002-12-06 2007-10-19 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
RU2228934C1 (ru) * 2003-05-20 2004-05-20 ООО "Исследовательский институт химического разнообразия" Замещенные 3,7-диазобицикло[3.3.1]нонаны, фокусированная библиотека и комбинаторная библиотека

Also Published As

Publication number Publication date
US8063219B2 (en) 2011-11-22
ZA200906784B (en) 2011-03-30
CL2008001048A1 (es) 2008-08-08
TWI403323B (zh) 2013-08-01
NI200900181A (es) 2011-07-25
IL201252A0 (en) 2010-05-31
AU2008252799A1 (en) 2008-11-27
WO2008142285A1 (fr) 2008-11-27
MY152839A (en) 2014-11-28
CN101687870B (zh) 2013-06-19
NZ580238A (en) 2012-03-30
RU2009137255A (ru) 2011-05-20
JP2010523630A (ja) 2010-07-15
SV2009003391A (es) 2010-07-02
ECSP099682A (es) 2009-12-28
CN101687870A (zh) 2010-03-31
PE20090235A1 (es) 2009-03-12
US20100137355A1 (en) 2010-06-03
RU2465276C2 (ru) 2012-10-27
CO6220973A2 (es) 2010-11-19
CU23854B1 (es) 2012-11-15
TW200904445A (en) 2009-02-01
IL201252A (en) 2014-08-31
AU2008252799B2 (en) 2013-08-15
EP2146994A1 (fr) 2010-01-27
FR2914923B1 (fr) 2013-06-14
BRPI0809593A2 (pt) 2014-09-30
MX2009010837A (es) 2010-01-15
CR11057A (es) 2010-04-12
PA8776401A1 (es) 2008-11-19
AR066023A1 (es) 2009-07-15
CU20090173A7 (es) 2011-10-14
HN2009002099A (es) 2012-01-05
EP2146994B1 (fr) 2015-07-01
GT200900266A (es) 2011-09-23
FR2914923A1 (fr) 2008-10-17
CA2683350A1 (fr) 2008-11-27
KR20090130126A (ko) 2009-12-17

Similar Documents

Publication Publication Date Title
UY31016A1 (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
ECSP11011183A (es) Compuestos orgánicos
ECSP11011184A (es) Compuestos orgánicos
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
UY30057A1 (es) Pirimidinas sustituidas con sulfoximinas, procesos para su producción y uso de las mismas como fármacos
DOP2011000176A (es) Compuestos organicos
CR11241A (es) Compuestos de pirazol y su uso como inhibidores de raf
UY30500A1 (es) Compuestos de azabencimidazolilo
CR20120113A (es) (heteroarilmetil)tiohidantoinas sustituidas como drogas anticancer
BRPI0514681A (pt) derivados de pirimidina
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
UY30881A1 (es) Derivados de fenotiazina, procedimientos y su uso como productos farmacéuticos
UY32168A (es) Nuevas composiciones de compuestos heterociclicos nitrogenados antibacterianos con otros compuestos antibacterianos y su utilización como medicamentos
BR112012011793A2 (pt) "acrilamidas heterocíclicas e seu uso como farmacêuticos"
DOP2006000202A (es) Derivados de carboxamida como antagonistas del receptor muscarinico
UY30856A1 (es) Nuevos derivados de 2,4 dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y principalmente como inhibidores de ikk
ECSP11010992A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
DOP2006000024A (es) Tiazolidinonas, su preparación y su uso como medicamento
EA201290229A1 (ru) Производные спиролактама и их применение
GB0602951D0 (en) Organic Compounds
UY30235A1 (es) Inhibidores de la adenilato ciclasa soluble
NI201200103A (es) NUEVOS DERIVADOS ( HETEROCICLO - TETRAHIDRO - PIRIDIN ) - ( PIPERAZINIL ) - 1 - ALCANONA Y ( HETEROCICLO - DIHIDRO - PIRROLIDIN ) - ( PIPERAZINIL ) - 1 - ALCANONA Y SU UTILIZACIÓN COMO INHIBIDORES DE p75

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170919